Cat.#: ACPP-1189
| Despition | PDE6C Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1705 | Human NXPH1 Protein (AC1705) | 5 µg | inquiry |
| ACPP-1090 | PAX5 Blocking Peptide (AC1090) | 250 µg | inquiry |
| ACPP-1325 | Synaptotagmin 1 Blocking Peptide (AC1325) | 250 µg | inquiry |
| ACPP-1075 | GABA B Receptor 2 Blocking Peptide (AC1075) | 250 µg | inquiry |
| ACPP-1446 | Human NDP Protein (AC1446) | 2 µg | inquiry |
| ACPP-1342 | ORP150 Blocking Peptide (AC1342) | 250 µg | inquiry |
| ACPP-1676 | Human RLBP1 Protein (AC1676) | 5 µg | inquiry |
| ACPP-1562 | Human TAGLN3 Protein (AC1562) | 5 µg | inquiry |
| ACPP-1086 | Synthetic Nanodisc Human Somatostatin Receptor 2 Protein (AC1086) | 10 µg | inquiry |
| ACPP-1673 | Human TIMM8A Protein (AC1673) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.